Merck BRAVECTO QUANTUM Approved for Year-Long Tick Protection
RAHWAY, N.J., March 2026 Merck Animal Health announced that the U.S. Food and Drug Administration (FDA) has approved BRAVECTO®...
Alzheimer’s Disease ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody NSCLC Oncology oncology innovation oncology research Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
RAHWAY, N.J., March 2026 Merck Animal Health announced that the U.S. Food and Drug Administration (FDA) has approved BRAVECTO®...
RAHWAY, N.J. | October 23, 2025 — Merck Animal Health (MSD Animal Health outside the U.S. and Canada), a...
RAHWAY, N.J., September 26, 2025 – Merck Animal Health, known as MSD Animal Health outside the U.S. and Canada...
